Treatment of children and adolescents with hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: Final results of the multinational trial GPOH-HD95

Journal of Clinical Oncology

Volumn 31, Issue 12, 2013, Pages 1562-1568

  Dörffel, Wolfgang ^a   Rühl, Ursula ^b   Lüders, Heike ^a   Claviez, Alexander ^c   Albrecht, Marion ^b   Bökkerink, Jos ^f   Holte, Harald ^g   Karlen, Jonas ^h   Mann, Georg ⁱ   Marciniak, Heinz ^a   Niggli, Felix ^k   Schmiegelow, Kjeld ^l   Schwarze, Ernst Wilhelm ^d   Pötter, Richard ^j   Wickmann, Lutz ^a   Schellong, Günther ^e  

^a Helios Hospital Berlin Buch   (Germany)

^b VIVANTES HOSPITAL   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d Dortmund Clinic   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ University of Medicine   (United States)

^j UNIVERSITY OF VIENNA   (Austria)

^k UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^l UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER; EUROPE; EVENT FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RISK ASSESSMENT; SCHOOL CHILD; TUMOR VOLUME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INTERNATIONAL AGENCIES; MALE; NEOPLASM GRADING; NEOPLASM STAGING; PREDNISONE; PROCARBAZINE; PROGNOSIS; REMISSION INDUCTION; SURVIVAL RATE; VIDARABINE; VINCRISTINE;

EID: 84876585372     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.45.3266     Document Type: Article

References (40)

1. Brǎmswig J, Hǒrnig-Franz I, Riepenhausen M, et al: The challenge of pediatric Hodgkin's disease: Where is the balance between cure and long-term toxicity? A report of the West German multicenter studies DAL-HD-78, DAL-HD-82 and DAL-HD-85. Leuk Lymphoma 3:183-193, 1990
2. Schellong G, Hǒrnig-Franz I, Rath B, et al: [Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood: A report of the cooperative DAL-HD-87 therapy study.] Klin Padiatr 206:253-262, 1994 (Pubitemid 24248161)
3. Schellong G: Treatment of children and adolescents with Hodgkin's disease: The experience of the German-Austrian Paediatric Study Group. Baillieres Clin Haematol 9:619-634, 1996 (Pubitemid 26362749)
4. Schellong G, Pǒtter R, Brǎmswig J, et al: High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: The German-Austrian multicenter trial DAL-HD-90 - The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol 17:3736-3744, 1999
5. Donaldson SS, Kaplan HS: Complications of treatment of Hodgkin's disease in children. Cancer Treat Rep 66:977-989, 1982 (Pubitemid 12129384)
6. Dǒrffel W, Lǔders H, Rǔhl U, et al: Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook. Klin Pǎ diatr 215: 139-145, 2003 (Pubitemid 36718285)
7. Swerdlow SH, Campo E, Harris NL, et al: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, ed 4. Lyon, France, IARC, 2008, pp 321-334
8. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994 (Pubitemid 24273002)
9. Bennett MH, MacLennan KA, Easterling MJ, et al: The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin's disease: An analysis of 271 non-laparotomised cases (BNLI report no. 22). Clin Radiol 34:497-501, 1983 (Pubitemid 13001105)
10. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861, 1971
11. Dieckmann K, Pǒtter R, Wagner W, et al: Up-front centralized data review and individualized treatment proposals in a multicenter pediatric Hodgkin's disease trial with 71 participating hospitals: The experience of the German-Austrian pediatric multicenter trial DAL-HD-90. Radiother Oncol 62:191- 200, 2002 (Pubitemid 34286452)
12. Kaplan ES, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Cox DR: Regression models and life-tables. J R Stat Soc B 42:187-220, 1972
14. Hancock SL, Cox RS, McDougall IR: Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 325:599-605, 1991
15. Hancock SL, Donaldson SS, Hoppe RT: Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1208-1215, 1993 (Pubitemid 23199121)
16. Tarbell NJ, Gelber RD, Weinstein HJ, et al: Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood. Lancet 341: 1428-1432, 1993 (Pubitemid 23161443)
17. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994 (Pubitemid 24056405)
18. Swerdlow AJ, Douglas AJ, Hudson GV, et al: Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 304:1137-1143, 1992
19. Tucker MA, Jones PH, Boice JD Jr., et al: Therapeutic radiation at a young age is linked to secondary thyroid cancer: The Late Effects Study Group. Cancer Res 51:2885-2888, 1991
20. Henry-Amar M: Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's Disease. Ann Oncol 3:117-128, 1992 (suppl 4)
21. Mauch PM, Kalish LA, Marcus KC, et al: Longterm survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1:33-42, 1995
22. Meadows AT, Obringer AC, Marrero O, et al: Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Pediatr Oncol 17:477-484, 1989 (Pubitemid 20018259)
23. Olweny CL, Katongole-Mbidde E, Kiire C, et al: Childhood Hodgkin's disease in Uganda: A ten year experience. Cancer 42:787-792, 1978 (Pubitemid 8406612)
24. Jacobs P, King HS, Karabus C, et al: Hodgkin's disease in children: A ten-year experience in South Africa. Cancer 53:210-213, 1984 (Pubitemid 14180729)
25. Baez F, Ocampo E, Conter V, et al: Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua. Ann Oncol 8:247-250, 1997 (Pubitemid 27153490)
26. Arya LS, Dinand V, Thavaraj V, et al: Hodgkin's disease in Indian children: Outcome with chemotherapy alone. Pediatr Blood Cancer 46:26-34, 2006 (Pubitemid 41779314)
27. Yaniv I, Saab A, Cohen IJ, et al: Hodgkin disease in children: Reduced tailored chemotherapy for stage I-II disease. J Pediatr Hematol Oncol 18:76-80, 1996 (Pubitemid 26048530)
28. van den Berg H, Stuve W, Behrendt H: Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy. Med Pediatr Oncol 29:23-27, 1997 (Pubitemid 27194735)
29. Hakvoort-Cammel FG, Buitendijk S, van den Heuvel-Eibrink M, et al: Treatment of pediatric Hodgkin disease avoiding radiotherapy: Excellent outcome with the Rotterdam-HD-84-protocol. Pediatr Blood Cancer 43:8-16, 2004 (Pubitemid 38738266)
30. Kung FH, Schwartz CL, Ferree CR, et al: POG 8625: A randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with stages I, IIA, IIIA1 Hodgkin disease: A report from the Children's Oncology Group. J Pediatr Hematol Oncol 28:362-368, 2006 (Pubitemid 43970392)
31. Nachman JB, Sposto R, Herzog P, et al: Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 20:3765- 3771, 2002
32. Wolden SL, Chen L, Kelly KM, et al: Longterm results of CCG 5942: A randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma - A report from the Children's Oncology Group. J Clin Oncol 30:3174-3180, 2012
33. Mauz-Kǒrholz C, Hasenclever D, Dǒrffel W, et al: Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: The GPOH-HD-2002 study. J Clin Oncol 28:3680-3686, 2010
34. Metzger ML, Weinstein HJ, Hudson MM, et al: Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA 307: 2609-2616, 2012
35. Keller FG, Castellino SM, Nachman JB: What is the best treatment for children with limited-stage Hodgkin lymphomǎ Curr Hematol Malig Rep 4:129- 135, 2009
36. Armitage JO: Early-stage Hodgkin's lymphoma. N Engl J Med 363:653-662, 2010
37. Maeda LS, Lee M, Advani RH: Current concepts and controversies in the management of early stage Hodgkin lymphoma. Leuk Lymphoma 52:962- 971, 2011
38. Straus DJ: Chemotherapy only for localized Hodgkin lymphoma. J Intern Med 270:197-205, 2011
39. Schellong G, Riepenhausen M, Bruch C, et al: Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies. Pediatr Blood Cancer 55:1145-1152, 2010
40. Kǒrholz D, Wallace WH, Landman-Parker J: Euro-Net-Paediatric Hodgkin's Lymphoma Group (Euro-Net-PHL-C1): First international inter-group study for classical Hodgkin's lymphoma in children and adolescents. http://clinicaltrials.gov/ct/show/NCT00433459:2012